Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00505518 · ClinicalTrials.gov registry record · NA

Investigating the Effectiveness of Telepsychiatry for Treating Major Depression in a Chinese American Nursing Home

A NA study of Major Depressive Disorder, sponsored by Massachusetts General Hospital.

Completed
Registry status
NA
Development phase
9
Enrollment target
2
Study locations

NCT00505518: Completed NA study of Major Depressive Disorder, sponsored by Massachusetts General Hospital.

NCT00505518 is a NA study of Major Depressive Disorder that has completed, run by Massachusetts General Hospital. The registered enrollment target is 9 participants, below the 377-participant average among 282 other Major Depressive Disorder trials with a reported enrollment target (98% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00505518, a NA study of Major Depressive Disorder, has completed, sponsored by Massachusetts General Hospital.

COMPLETED
Registry status
NA
Development phase
9 participants
Enrollment target
2
Study locations

Study Summary

The current use of telepsychiatry, or psychiatric care using videoconferencing, is very limited. The present study investigates the use of this method with a depressed Chinese American population in a nursing home. It is believed that this population can benefit from telepsychiatric treatment when used in collaboration with the primary care they receive in the nursing home.

Primary Outcome

Minimum score - 1 (better outcome) Maximum score - 7 (worse outcome)

Conditions Studied

Interventions

  • DRUG Psychotropic medication (at discretion of psychiatrist)
  • BEHAVIORAL Collaborative psychiatric and primary medical care

Study Locations (2)

Massachusetts

  • Depression and Clinical Research Program at Massachusetts General Hospital - Boston
  • South Cove Manor - Boston

Trial Details

FieldValue
Enrollment Target 9 participants
Start Date 2006-09
Est. Completion 2007-11
Phase NA
Massachusetts General Hospital

2,032 total trials

What the finished NCT00505518 record still lists

NCT00505518 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 9 participants, a relatively small participant target, below the 377-participant average among 282 other Major Depressive Disorder trials with a reported enrollment target (98% lower).

The record links to 1 condition, with Major Depressive Disorder appearing as the primary indexed condition, and to 2 interventions - of which Psychotropic medication (at discretion of psychiatrist) is the first listed.

NCT00505518 reports a single indexed study location in Massachusetts.

Frequently Asked Questions

What is clinical trial NCT00505518 about?

NCT00505518 is a clinical study titled "Investigating the Effectiveness of Telepsychiatry for Treating Major Depression in a Chinese American Nursing Home". The current use of telepsychiatry, or psychiatric care using videoconferencing, is very limited. The present study investigates the use of this method with a depressed Chinese American population in a nursing home. It is believed that this population can benefit from telepsychiatric treatment when u...

What is the current status of trial NCT00505518?

This trial is currently completed. It is a NA study. The enrollment target is 9 participants. The study started on 2006-09. Estimated completion is 2007-11.

What conditions does trial NCT00505518 study?

This clinical trial studies the following conditions: Major Depressive Disorder.

What interventions are being tested in trial NCT00505518?

The interventions under investigation include: Psychotropic medication (at discretion of psychiatrist) (DRUG), Collaborative psychiatric and primary medical care (BEHAVIORAL).

Who is sponsoring clinical trial NCT00505518?

This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00505518 being conducted?

This trial has 2 study locations across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Major Depressive Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT00505518's enrollment target sits among peer trials

9 279th of 282 higher than 4 of 282 other Major Depressive Disorder trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Major Depressive Disorder trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00505518, the US trial registry maintained by the National Library of Medicine. NCT00505518 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.